Tarsus Medical Overview

  • Founded
  • 2009
  • Status
  • Acquired/​Merged
  • Employees
  • 4
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $4.7M
Latest Deal Amount

Tarsus Medical General Information


Developer of solutions and devices for unsolved problems within the field of podiatry.

Contact Information

Formerly Known As
Yeti Medical
Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Primary Office
  • 465 Fairchild Drive
  • Mountain View, CA 94043
  • United States
+1 (650) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tarsus Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 24-Jan-2013 $4.7M 00.000 00.00 Completed Startup
4. Debt - General 16-Jul-2012 00000 00.000 Completed Startup
3. Debt - General 10-Nov-2011 000 00.000 Completed Startup
2. Early Stage VC 17-Feb-2011 $2.52M $3.04M Completed Startup
1. Debt - General 25-Jun-2010 $510K $510K Completed Startup
To view Tarsus Medical’s complete valuation and funding history, request access »

Tarsus Medical Executive Team (3)

Name Title Board Seat Contact Info
Doreen Brown Chief Executive Officer
Jason Lettmann Co-Founder
To view Tarsus Medical’s complete executive team members history, request access »

Tarsus Medical Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tarsus Medical Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Split Rock Partners Venture Capital Minority 000 0000 000000 0
To view Tarsus Medical’s complete investors history, request access »